RGEN 8-K 2026-10-30

REPLIGEN CORP (RGEN) 8-K dated 2026-10-30 — accession 0001628280-26-068382.

REPLIGEN CORP (RGEN) is a medical instruments & supplies company listed on NASDAQ.

REPLIGEN CORP filed a 8-K on 2026-10-30. Accession 0001628280-26-068382.

This 8-K covers: Unregistered share sale (Item 3.02), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported RGEN revenue for 2025-12-31 was $738.3M. Net income was $48.9M. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. RGEN currently screens at market cap $7.43B.

Not investment advice. The RGEN SEC hub lists recent forms. The stock page is the research view.